The principles set out in the UK Corporate Governance Code remain the primary standards and guidance for corporate governance within AstraZeneca. The Board, its Committees and individual Directors apply those principles in all aspects of their work.
I am pleased to introduce our Directors’
Remuneration Report (the Report) for 2011 for which we seek approval at the Company’s AGM in April.
In this section we describe our key
Risk PDF (109Kb)
and assurance mechanisms and the
principal risks and
uncertainties we face.